Trupanion, based in Seattle, offers medical insurance for pets and went public in 2014. It operates in Subscription and Other Business segments, providing software and various insurance products.
Based on our analysis, Trupanion has received an overvalued rating of 1 out of 5 stars due to several concerning financial metrics that significantly underperform against its sector.
One key ratio is the net profit margin, which stands at -0.75%. This figure indicates that the company is operating at a loss, meaning it is unable to generate profit from its revenues. In contrast, the sector average net profit margin is 18.27%, showcasing a substantial disparity that suggests Trupanion is struggling to manage its costs or generate sufficient sales for profitability.
Another critical metric is the return on equity (ROE), which is reported at -2.98%. ROE measures a company's ability to generate profit from shareholders' equity. A negative ROE indicates that shareholders are not seeing a return on their investment, which is troubling compared to the sector average of 8.04%. This suggests that Trupanion is not effectively utilizing its equity to drive earnings.
Additionally, the return on assets (ROA) for Trupanion is -1.19%, which highlights the company's inefficiency in using its assets to produce earnings. The sector average ROA is 0.88%, indicating that Trupanion is underperforming in asset management compared to its peers.
These financial ratios illustrate significant challenges that Trupanion faces in achieving profitability and efficient asset utilization, leading to its overvalued rating.
This is not a comprehensive overview of our valuation, and should not be viewed as financial advice. Always do your own research before considering an investment.
📡️ Financials
Overvalued
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.